🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
Status
Terminated
Location
The General Hospital of People?s Liberation Army (301 Hospital)
Start Date
2022-03-01
Trial ID
NCT05251948
Treatments Being Tested
To learn if atezolizumab in combination with oxaliplatin and 5-fluorouracil...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-02-19
Trial ID
NCT03784326
Treatments Being Tested
To learn if treatment with tiragolumab and atezolizumab before and after st...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-06-02
Trial ID
NCT05681039
Treatments Being Tested
An open-label, Phase I/Ib study investigating the safety and efficacy of ti...
Status
Active Not Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-04-13
Trial ID
NCT06760481
Treatments Being Tested
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
Status
Recruiting
Location
UC Irvine Medical Center
Start Date
2020-11-01
Trial ID
NCT04524871
The peculiarity of anal cancers, with well-established radical chemoradioth...
Status
Recruiting
Location
Hospital Universitario Son Espases
Start Date
2023-02-14
Trial ID
NCT05661188
Treatments Being Tested
This study will evaluate the surgical safety and feasibility of atezolizuma...
Status
Terminated
Location
City of Hope Cancer Center
Start Date
2021-04-23
Trial ID
NCT04832854
Treatments Being Tested
The goal of this clinical research study is to learn if the combination of ...
Status
Active Not Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-04-11
Trial ID
NCT06754501
Treatments Being Tested
The prognosis of ESCC is poor with a five-year overall survival rate of 10 ...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2023-09-18
Trial ID
NCT05743504
Treatments Being Tested
To determine the effect of neoadjuvant atezolizumab alone or in combination...
Status
Active Not Recruiting
Location
University of San Francisco, California
Start Date
2019-03-08
Trial ID
NCT03708224
Treatments Being Tested